New York State Common Retirement Fund’s Damora Therapeutics DMRA Stock Holding History

New York State Common Retirement Fund’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$489K	Buy	+18,800	New	+$455K	﹤0.01%	2009

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

New York State Common Retirement Fund's DMRA Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 18,800 shares worth $489K. The stake represents ﹤0.01% of the portfolio and ranks #2009 among its holdings.

104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

New York State Common Retirement Fund held 18,800 shares of Damora Therapeutics worth $489K as of Q2 2026.
Damora Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
Damora Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2009 holding.
104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.